Perioperative HMG-CoA-Reductase-Inhibitors: A Pilot Study Assessing the Role of "Statin" Therapy and Perioperative Inflammatory Response in Patients Undergoing Major Orthopedic Surgery
Phase of Trial: Phase IV
Latest Information Update: 23 May 2017
At a glance
- Drugs Simvastatin (Primary) ; Simvastatin (Primary)
- Indications Atherosclerosis
- Focus Biomarker; Pharmacodynamics
- 03 Jun 2014 Planned End Date changed from 1 Jun 2013 to 1 Apr 2015 as reported by ClinicalTrials.gov record.
- 22 May 2012 Planned End Date changed from 1 Jun 2011 to 1 Jun 2013 as reported by ClinicalTrials.gov record.
- 19 Apr 2011 New trial record